|
⚲
|
| Keyboard |
| Navarre Paul
✚
|
|
|---|---|
| CIK # | 0001637145 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001637145] | |
| 4 | [0001637145] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Navarre Paul | |
| Allergan PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2015-03-17 | Grant | 808 | ||
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2015-03-17 | Grant | 1,070 | ||
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2015-03-17 | Grant | 2,845 | ||
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2015-03-17 | Grant | 217 | ||
|
Allergan PLC ACT
Performance-Based Restricted Stock Unit · derivative
|
2015-03-17 | Grant | 9,344 | $0.00 | |
|
Allergan PLC ACT
Stock Option (Right to Buy · derivative
|
2015-03-17 | Grant | 8,676 | $0.00 | |
|
Allergan PLC ACT
Stock Option (Right to Buy) · derivative
|
2015-03-17 | Grant | 7,726 | $0.00 | |
|
Allergan PLC ACT
Stock Option (Right to Buy) · derivative
|
2015-03-17 | Grant | 8,156 | $0.00 | |
|
Allergan PLC ACT
Stock Option (Right to Buy) · derivative
|
2015-03-17 | Grant | 7,752 | $0.00 | |
|
Allergan PLC ACT
Stock Option (Right to Buy) · derivative
|
2015-03-17 | Grant | 9,499 | $0.00 |